SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel.

Polyrizon Ltd.

Polyrizon Ltd. Ordinary Shares

PLRZ is trending due to positive preclinical data for its intranasal naloxone hydrogel, with the community actively debating whether the stock will continue to squeeze or face dilution. The stock's low float and previous reverse splits are fueling volatility, while some traders are drawing comparisons to similar plays like $SMX and anticipating a potential multi-day run.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending as investors anticipate earnings, focusing on the company's progress in AI automation and partnerships with major tech players like Nvidia and Google. The community is actively discussing the potential for a short squeeze and a significant breakout if earnings and guidance impress. Some analysts highlight UiPath's transition from RPA to a broader AI platform, while others remain cautious, pointing to the need for stronger revenue growth.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Bozeman, MT.

Snowflake Inc

Snowflake is trending as analysts are turning bullish, with recent upgrades and raised price targets fueled by the anticipation of AI-driven growth and a new partnership with Palantir. The community is actively discussing the potential impact of this collaboration, while some investors express concerns about the stock's valuation and profitability metrics. Overall, SNOW is experiencing heightened attention due to positive sentiment and its strategic positioning within the cloud and AI sectors.

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.

Aquestive Therapeutics Inc

Aquestive Therapeutics is trending as investors weigh the prospects of Anaphylm's upcoming FDA decision, especially against the backdrop of competitor SPRY's earnings. Community discussions revolve around the likelihood of approval, the potential impact of a competitor's petition, and the possibility of a buyout. Bullish investors highlight positive analyst ratings and the convenience of Anaphylm's delivery method, while others express concerns about market conditions and potential delays.

UP Fintech Holding Ltd. is an online brokerage firm that focuses on global investors. It provides an online trading platform that enables investors to trade in equities and other financial instruments on multiple exchanges around the world. The firm offers products and services, as well as a user experience to customers through its mobile first strategy. The company was founded by Tian Hua Wu in June 2014 and is headquartered in Singapore.

UP Fintech Holding Ltd - ADR

UP Fintech Holding ($TIGR) is trending amid discussions of strong Q3 earnings, with community members highlighting record revenue and profit. Optimistic investors believe $TIGR is undervalued compared to competitors like $FUTU and $HOOD, focusing on its potential for growth in the Asian markets. Despite some concerns around resistance levels, many are anticipating a significant price increase.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth Inc is trending amid discussions about its strategic partnership with Solvay and its potential role in supplying rare earth materials, particularly Samarium, for magnet production. Community members are weighing the impact of this partnership and the broader implications for U.S. rare earth independence, especially in light of geopolitical tensions and the upcoming Russell 2000 index inclusion.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce stock is trending due to its recent revenue forecast and discussions around AI integration, with the community debating the company's future and the potential impact of Agentforce. Despite mixed financial results and concerns about AI disrupting its core business, some analysts maintain a positive outlook. The stock's volatility and leadership are also focal points, with some suggesting a need for fresh perspectives.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as the community discusses its potential, with some highlighting the QNX technology's growing adoption in the automotive industry and recent partnerships. Bullish sentiment is fueled by expectations for upcoming earnings and long-term growth, while others point to ongoing market manipulation. Investors are closely watching for a breakout above key resistance levels.

Serve Robotics, Inc. engages in providing self-driving delivery. It designs, develops, and operates zero-emissions robots that serve people in public spaces, starting with food delivery. The company was founded by Ali Kashani, Dmitry Demeshchuk and MJ Burk Chun in 2017 and is headquartered in Redwood City, CA.

Serve Robotics Inc

SERV is trending as traders discuss the recent partnership with Doordash and potential executive order by Trump, anticipating benefits to the robotics sector. Community members are weighing the impact of this partnership, speculating on revenue growth and comparing SERV to other robotics companies. Bullish sentiment is fueled by expectations of increasing deployment and revenue, though some are wary of insider selling and short-term volatility.

Genius Sports Ltd. engages in the provision of scalable, technology-led products and services to the sports, sports betting, and sports media industries. It also involves in Sports League, which offers technology infrastructure for the collection, integration, and distribution of live data; Sportsbooks, which includes collection of live sports data, odds making, risk management and player marketing; and Sports Media, which provides a range of online marketing and fan engagement tools. The company was founded by Mark Adrian Locke in 2000 and is headquartered in London, United Kingdom.

Genius Sports Limited

Genius Sports ($GENI) is trending amid analyst upgrades and raised price targets, driven by optimism surrounding its expanding data and technology platform. The community is discussing the company's strong positioning in the sports betting industry and potential for increased free cash flow conversion. Investors are also closely watching the upcoming Investor Day for further insights into the company's growth strategy.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer

Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer PR Newswire MORRISTOWN, N.J., Dec. 1, 2025...

Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference

Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference PR Newswire...

Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London

Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London PR Newswire MORRISTOWN...

What is HC Wainwright's Estimate for WHWK FY2025 Earnings?

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK - Free Report) - Research analysts at HC Wainwright cut their FY2025 earnings estimates for shares of Whitehawk Therapeutics in a note issued to investors on...

Whitehawk Therapeutics (NASDAQ:WHWK) Releases Quarterly Earnings Results, Beats Estimates By $0.25 EPS

Whitehawk Therapeutics (NASDAQ:WHWK - Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.26) earnings per share (EPS) for the quarter, beating the consensus...

Whitehawk Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights

Whitehawk Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights Whitehawk Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights PR Newswire...

Whitehawk Therapeutics Presents Real-World Analysis Confirming PTK7 as a Broadly Expressed, Clinically Relevant Target Across Solid Tumors at AACR-NCI-EORTC

Whitehawk Therapeutics Presents Real-World Analysis Confirming PTK7 as a Broadly Expressed, Clinically Relevant Target Across Solid Tumors at AACR-NCI-EORTC Whitehawk Therapeutics Presents Real-World...

Tempus AI Fuels Growth Through Strategic Biotech Collaborations

TEM expands its AI-driven growth with new collaborations in oncology, neurogenomics, and diagnostic innovation.

Healthtech company Tempus AI (TEM) announced a multi-year collaboration with Whitehawk Therapeutics (WHWK) on Thursday, aimed at developing the latter’s cancer treatment pipeline.Under the <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.tempus.com/news/pr/tempus-announces-collaboration-with-whitehawk-therapeutics-to-advance-biomarker-driven-oncology-research/">deal</a>, Whitehawk Therapeutics will apply Tempus’ real-world dataset, including a de-identified multimodal database, to support its clinical trial designs. A de-identified multimodal database is a collection of diverse datasets, such as medical images, clinical notes, and genetic information, from which all personally identifiable information or protected health information has been removed. It is expected that Tempus’ dataset will help Whitehawk focus on the right patient population.Whitehawk’s antibody drug conjugate portfolio includes three assets designed to target proteins that are broadly expressed in high-potential cancer indications, such as lung and gynecological cancers. The collaboration is aimed at advancing research centered on these candidates.“By partnering with Tempus, our goal is to better understand the expression of our ADC protein targets to inform indication prioritization for our clinical development programs and better exploit the full potential of our pipeline,” said Whitehawk CEO Dave Lennon.<a href="https://stocktwits.com/symbol/WHWK">Whitehawk shares</a> soared 23% on Thursday afternoon at the time of writing, while <a href="https://stocktwits.com/symbol/TEM">Tempus shares</a> dropped about 0.5%.On Stocktwits, retail sentiment around WHWK jumped from ‘neutral’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘high’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:590/61;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_16_at_12_26_39_PM_png_87d1a96f13.webp" alt="WHWK's Sentiment Meter and Message Volume as of 12:27 p.m. ET on Oct. 16, 2025 | Source: Stocktwits" width="590" height="61"><figcaption>WHWK's Sentiment Meter and Message Volume as of 12:27 p.m. ET on Oct. 16, 2025 | Source: Stocktwits</figcaption></figure>Retail sentiment around TEM, however, stayed within the ‘bearish’ territory, accompanied by ‘low’ message volume.<figure class="image"><img style="aspect-ratio:591/61;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_16_at_12_29_47_PM_png_cc45006531.webp" alt="TEM's Sentiment Meter and Message Volume as of 12:27 p.m. ET on Oct. 16, 2025 | Source: Stocktwits" width="591" height="61"><figcaption>TEM's Sentiment Meter and Message Volume as of 12:27 p.m. ET on Oct. 16, 2025 | Source: Stocktwits</figcaption></figure> A Stocktwits user hopes WHWK rallies into the $4 to $5 range.<stembedurl>https://stocktwits.com/cjstocksup/message/632578934</stembedurl>Another sounded optimistic for TEM stock, citing its relationships with big pharma and strong backlog.<stembedurl>https://stocktwits.com/TICKERTUTOR/message/632569480</stembedurl>WHWK stock has dropped 18% this year, while TEM shares rose 171% during the period.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/sunshine-biopharma-stock-rises-after-launch-of-generic-cholestrol-lowering-drug-by-canadian-unit/ch6p4DqR3nu">Sunshine Biopharma Stock Powers Ahead Following Launch Of Generic Cholesterol-Lowering Drug By Canadian Unit</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration logo of Tempus AI is seen on a smartphone against a screen displaying a trade markets illustration on April 15, 2024 in Krakow, Poland. (Photo by Dominika Zarzycka/NurPhoto via Getty Images)

Whitehawk Therapeutics Stock Rallies 25% On Tempus AI Collaboration Deal: Retail Hopes For A Rally Toward $5 Mark

Under the deal, Whitehawk Therapeutics will apply Tempus’ real-world dataset, including, de-identified multimodal database, to support its clinical trial designs.

Equity

Under the deal, Whitehawk Therapeutics will apply Tempus’ real-world dataset, including, de-identified multimodal database, to support its clinical trial designs.


Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a multi-year collaboration with Whitehawk Therapeutics, Inc. (NASDAQ...

Whitehawk Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai in November 2007 and is headquartered in Morristown, NJ.

WHWK
Whitehawk Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest WHWK News

WHWKWhitehawk Therapeutics Inc.